A platform that prints human tissue to help heal injury and disease

Founders

Tamer Mohammed

Sam Wadsworth

Simon Beyer

INDUSTRY

Biotechnology (Healthcare)

MILESTONE

Radical Investment: 2020

Aspect Biosystems occupies a unique place in the biotech market, having developed a platform for in-house innovation and licensed research partnerships with academia and industry. The promise of this technology – and its platform model – could reshape the business of tissue therapeutics.

Current tissues under development in Aspect’s bio engineering pipeline include personalized liver tissue as well as a pancreatic tissue for type 1 diabetes. Aspect’s proprietary bioprinting platform is behind over 20 collaboration projects with leading pharma, biotech and research centres around the world. In 2019 Aspect announced deals with GSK, Merck and JSR.

Founders

Tamer Mohamed,
Sam Wadsworth,
Simon Beyer

Founders

Himanshu Gupta,
Max Evans

Founders

Aidan Gomez,
Nick Frosst,
Ivan Zhang

Founders

Pieter Abbeel,
Peter Chen,
Rocky Duan,
Tianhao Zhang

Founders

Fei-Fei Li,
Dr. Arnold Milstein

Founders

Evan Feinberg,
Ben Sklaroff

Founders

Ramtin Attar,
Reza Nasseri

Founders

Rishi Nayyar,
Harsh Nayyar

Founder

Benjamin Schmidt

Founder

Corey Gross

Founder

Ben Nashman

Founders

Martin Snelgrove,
Darrick Wiebe

Founders

Raquel Urtasun

Founders

Christian Weedbrook

© 2021 Radical Ventures Investments Inc.